Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,532.40
(
0.00%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
93.43
(
2.27%
)
Bitcoin
72,813.84
(
-1.01%
)
News Focus
News Focus
Post# of 3431
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Fred Kadiddlehopper

Send PM Follow Ignore
Followers 28
Posts 5022
Boards Moderated 0
Alias Born 09/22/2006

Fred Kadiddlehopper

Re: None

Tuesday, 04/21/2026 10:45:15 AM

Tuesday, April 21, 2026 10:45:15 AM

Post# of 3431

The CEO of Unicycive Therapeutics (UNCY), Shalabh Gupta, has cited the U.S. market for phosphorus binders as a >$1 billion opportunity.
Unicycive
Unicycive
+3
The company expects to capture a significant portion of this market following the potential approval and 2026 launch of its lead asset, Oxylanthanum Carbonate (OLC):
Revenue Goal: Unicycive expects OLC to achieve sales of $500 million+ annually.



I confess that with my undiagnosed and untreated ADD I might be reading this completely out of context.

The more you know, the less you don't know.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent UNCY News
More UNCY News